Portfolio Companies 2026 for Ysios Capital: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Ysios Capital accounts for 15 tracked companies with verified cap-table data, 15 of which disclose round sizes totalling $1.5B. The median disclosed raise is $83M, and the largest is AM Pharma at $176M, ahead of Splice Bio ($170M) and SparingVision ($147M).
The names that recur most often on these portfolio cap tables are Ysios Capital (15 companies), Gilde Healthcare (6 companies), Kurma Partners (4 companies), Novartis Venture Fund (4 companies), LSP (3 companies), Sanofi Ventures (3 companies). By latest disclosed round, the market skews Series A (7), Series C (4), Series B (3), Growth (1).
Companies tracked: 15
Disclosed funding total: $1.5B across 15 companies
Median disclosed raise: $83M
Largest raise: AM Pharma — $176M
Stage mix: Series A 7 · Series C 4 · Series B 3 · Growth 1
